Showing results (191-200 of 573) with videos related to
Sort By:
Pageof 58
Therapeutic Advances in Infectious Disease|June 27, 2025
Risk factors for multiple skin abscesses among community-recruited people who inject drugs in Los Angeles, CA, and Denver, CO: a cross-sectional studySiddhi S Ganesh, Gilbert A Orta Portillo, Daniel R Trigo, et al.Therapeutic Advances in Infectious Disease|July 15, 2025
Perspectives on syringe services programs among patients hospitalized with injection drug use-associated endocarditis: a qualitative studyBailey McInnes, Eunice A Okumu, Maisun M Ansary, et al.Therapeutic Advances in Infectious Disease|June 30, 2025
Voriconazole versus isavuconazole for invasive aspergillosis: a retrospective analysis in a medically insured U.S. population (2017-2020)Sophea Chan, Laura Leigh Stoudenmire, Xianyan Chen, et al.Therapeutic Advances in Infectious Disease|June 23, 2025
Selective reporting of antibiotic susceptibility testing results: a retrospective evaluation of a nudging strategy to improve antibiotic prescribing for ampC-producing Enterobacterales infections in hospitalized adultsAndy Lim, Terrence McSweeney, Phyu M Thwe, et al.Therapeutic Advances in Infectious Disease|December 29, 2025
Imidazolopiperazines as next-generation antimalarial agents: a scoping review of efficacy, mechanisms of action and resistance; prospects for future developmentFatoumata Ousmane Maiga, Laurent Dembele, Mohamed Maiga, et al.Therapeutic Advances in Infectious Disease|May 12, 2025
Recombinant interleukin-7 treatment of refractory Mycobacterium avium complex lung disease (IMPULSE-7): a pilot phase II, single-center, randomized, clinical trialCarlos Mejia-Chew, Andrej Spec, Andrew H Walton, et al.Therapeutic Advances in Infectious Disease|November 5, 2025
Entomo-virological surveillance of arboviruses in the Americas: prospects for the use of paper-based nucleic acid stabilization materialsRosana Pérez-Franco, Daniel B Ramírez-Osorio, Joel Monroy-Carreño, et al.Therapeutic Advances in Infectious Disease|September 17, 2025
Prevalence, molecular carbapenemase detection, and antibiotic resistance of carbapenem-resistant Enterobacterales in a tertiary care hospital in East Jerusalem (2019-2023): a retrospective studyLilian AbuHadba, Mousa Hindiyeh, Ali Sabateen, et al.Therapeutic Advances in Infectious Disease|September 9, 2025
Characterization of the clinical features, laboratory findings, and outcomes of human fascioliasis in a global network: a retrospective mutlicenter studyAndrés F Henao-Martínez, Juan C Celis-Salinas, Martin Casapia-Morales, et al.Therapeutic Advances in Infectious Disease|August 29, 2014
Management of febrile neutropenia in the era of bacterial resistanceSehnaz Alp, Murat AkovaPageof 58